How an Ebola drug might fight Covid-19 virus

accreditation
It appears that there is a new use for an existing Ebola drug.
It appears that there is a new use for an existing Ebola drug.

An Ebola drug that's proven effective against some coronaviruses may also work against the new Covid-19 coronavirus, scientists say.

Remdesivir was developed by Gilead Sciences in response to the 2014 West African Ebola virus epidemic.

"We know the drug works against different coronaviruses, like MERS [Middle East respiratory syndrome] and SARS [severe acute respiratory syndrome], and we know the novel coronavirus is very similar to SARS," said virologist Matthias Götte, of the University of Alberta in Canada. "So I would say I'm cautiously optimistic that the results our team found with remdesivir and MERS will be similar with Covid-19."

The researchers said they discovered why remdesivir is effective in treating the MERS and SARS coronaviruses, and that's the key to their report.

Virus can no longer replicate

Until now, there hadn't been a published explanation of why remdesivir may work against coronaviruses.

"Even if you know a drug works, it can be a red flag if you don't know how it works," Götte said in a university news release. "It is reassuring if you know exactly how it works against the target.

"What our study showed was that remdesivir essentially mimics one of the natural building blocks for RNA synthesis necessary for genome replication of the virus," Götte said. When the drug is incorporated into the growing RNA chain, the virus can no longer replicate, the researchers found.

Results from ongoing clinical trials of remdesivir treatment in patients with Covid-19 are expected by the end of April. But even if remdesivir proves effective, it won't be a silver bullet.

Major improvement

"It's likely we'll need more than one drug to properly fight emerging diseases like Covid-19, as we have with HIV and hepatitis C virus infections," Götte said. "Ideally, we will have a couple of drugs because certain strains could be resistant to certain treatments."

A recent report in the New England Journal of Medicine reported that a patient with Covid-19 was given remdesivir on the seventh day of illness and showed major improvement the following day and eventually recovered.

At a recent press conference in Beijing, Dr Bruce Aylward, the assistant director-general of the World Health Organization, said remdesivir is the only drug available that may be effective against Covid-19.

The new study was published recently in the Journal of Biological Chemistry.

READ | This week in coronavirus – what science is currently saying

READ | 8 must read stories on the new coronavirus

WATCH | 6 handwashing mistakes that help coronavirus spread

Image credit: iStock

We live in a world where facts and fiction get blurred
In times of uncertainty you need journalism you can trust. For 14 free days, you can have access to a world of in-depth analyses, investigative journalism, top opinions and a range of features. Journalism strengthens democracy. Invest in the future today. Thereafter you will be billed R75 per month. You can cancel anytime and if you cancel within 14 days you won't be billed. 
Subscribe to News24
Voting Booth
Zama zama crackdown: What are your thoughts on West Village residents taking the law into their own hands?
Please select an option Oops! Something went wrong, please try again later.
Results
Authorities should bring in the army already
12% - 893 votes
Illegal miners can't be scapegoated for all crime
43% - 3201 votes
What else did we expect without no proper policing
41% - 3100 votes
Vigilante groups are also part of the problem
4% - 301 votes
Vote
Rand - Dollar
16.19
+2.4%
Rand - Pound
19.81
+1.1%
Rand - Euro
16.73
+1.2%
Rand - Aus dollar
11.47
+0.7%
Rand - Yen
0.12
+0.3%
Gold
1,797.83
+0.2%
Silver
20.73
+1.0%
Palladium
2,246.50
+1.1%
Platinum
943.50
+0.6%
Brent Crude
96.31
-0.4%
Top 40
63,191
-0.9%
All Share
69,789
-0.7%
Resource 10
64,439
-0.9%
Industrial 25
84,835
-1.2%
Financial 15
15,728
-0.1%
All JSE data delayed by at least 15 minutes Iress logo
Editorial feedback and complaints

Contact the public editor with feedback for our journalists, complaints, queries or suggestions about articles on News24.

LEARN MORE